Subscribe to RSS
DOI: 10.1055/s-2005-837499
Georg Thieme Verlag KG Stuttgart · New York
The Effects of Hormone Replacement Therapy on Oxidative DNA Damage in Postmenopausal Women: A Pilot Study
Auswirkungen einer Hormonsubstitutionstherapie auf oxidative DNA-Schädigungen in postmenopausalen Frauen: eine PilotstudiePublication History
Eingang Manuskript: 29.11.2004
Eingang revidiertes Manuskript: 3.1.2005
Akzeptiert: 7.1.2005
Publication Date:
21 March 2005 (online)
Zusammenfassung
Fragestellung: Ziel der Studie war es, die Auswirkungen einer Hormonsubstitutionstherapie (HST) auf oxidative DNA-Schädigungen in postmenopausalen Frauen auszuwerten.
Methode: Es wurden 81 postmenopausale Frauen für die Studie rekrutiert; die Konzentration von 8-Hydroxy-deoxyguanosine (8-OHdG) im Urin der Frauen wurde gemessen und mit den Ergebnissen einer Kontrollgruppe von Frauen im selben Alter (n = 40) verglichen. Die HST-Gruppe erhielt entweder konjugierte Östrogene oder Tibolone. Klinische Charakteristika und 8-OHdG-Konzentrationen wurden korreliert und zwischen den beiden Gruppen verglichen.
Ergebnisse: Die Urinkonzentration von 8-OHdG war niedriger in der HST-Gruppe verglichen mit der Kontrollgruppe: Der Unterschied war grenzwertig signifikant (7,13 ± 3,58 µg/g Kreatinin vs. 9,32 ± 7,29 µg/g Kreatinin, p = 0,079) (Mittel ± Standardabweichung). Es wurde kein signifikanter Unterschied der Urinkonzentrationen von 8-OHdG zwischen den verschiedenen HST-Untergruppen mit unterschiedlicher HST-Einnahmedauer festgestellt. Nach Berichtigung der altersspezifischen Daten zeigte sich, dass die HST eine signifikante Auswirkung auf die Konzentration von 8-OHdG im Urin hat, wobei die HST-Gruppe eine niedrigere Urinkonzentration von 8-OHdG aufwies, verglichen mit der Kontrollgruppe (p = 0,029).
Schlussfolgerung: Postmenopausale Frauen, die eine HST erhalten, haben möglicherweise eine geringere oxidative DNA-Schädigung als solche, die keine HST bekommen. Weitere, groß angelegte, prospektive und kontrollierte Studien sind erforderlich, um diese Ergebnisse zu bestätigen.
Abstract
Objective: To evaluate the effects of hormone replacement therapy (HRT) on oxidative DNA damage in postmenopausal women.
Materials and Methods: Eighty-one postmenopausal women who received HRT were recruited, and 8-hydroxy-deoxyguanosine (8-OHdG) levels were measured in the urine and compared with those of age-matched control (n = 40). The HRT group received either conjugate estrogens or tibolone. Clinical characteristics and urinary 8-OHdG levels were correlated and compared between the two groups.
Results: The urinary level of 8-OHdG was lower in the HRT group, compared to controls, with a borderline significance (7.13 ± 3.58 µg/g creatinine vs. 9.32 ± 7.29 µg/g creatinine, p = 0.079) (mean ± S.D.). There was no significant difference in urinary 8-OHdG levels among different HRT duration subgroups. After correcting for age, HRT showed a significant effect on the urinary level of 8-OHdG, and the HRT group showed a lower urinary level of 8-OHdG, compared to controls (p = 0.029).
Conclusion: Post-menopausal women receiving HRT may have a lower level of DNA oxidative damage than those not receiving HRT. Further larger-scale, prospective controlled investigations are necessary to confirm these results.
Schlüsselwörter
HST - oxidative DNA-Schädigung - 8-OHdG
Key words
HRT - oxidative DNA damage - 8-OHdG
References
- 1 Speroff L, Fritz M A. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia; Lippincott, Williams & Wilkins 2005: 691
- 2 Brett K M, Madans J H. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol. 1997; 145 536-545
- 3 Park H M, Choi H, Lee H K. The HRT awareness and acceptance in Korean postmenopausal women - results of Korean Gallup Epidemiologic Survey On Menopause and HRT. J Kor Soc Menopause. 2002; 8 3-18
- 4 Jantke A, Buhling K J, Sehouli J, Pfuller B, Hindenburg H J, Lichtenegger W. Has the WHI study affected hormone replacement therapy in clinical practice? A survey of gynecologists in Berlin. Geburtsh Frauenheilk. 2003; 63 560-565
- 5 Lobo R A. Treatment of the Menopausal Women. 2nd ed. Philadelphia; Lippincott, Williams & Wilkins 1999 157-178 195-202
- 6 Speroff L, Glass R H, Kase N G. Clinical Gynecologic Endocrinology and Infertility. 6th ed. Philadelphia; Lippincott, Williams & Wilkins 1999: 684-700
- 7 Morr A K, Ohlmann P, Jung F, Mrowietz C, Sutterlin M, Dietl J, Schmidt W. Influence of postmenopausal hormone replacement therapy on cutaneous microcirculation. Geburtsh Frauenheilk. 2003; 63 243-247
- 8 Hadji P, Rabe T, Ortmann O, Mueck A O, von Holst T, Emons G, Schulz K D. The possible role of estrogens and progestagens in the prevention of osteoporosis. Geburtsh Frauenheilk. 2002; 62 436-445
-
9 Korea National Statistics Office .Population Census, 2002. http://www.nso.go.kr/
.
- 10 Ku P S. Anti-Aging Medicine. Seoul; Calvin Publishing 2003: 37-43
-
11 Harman D.
Free radical theory of aging. Klatz R, Goldman R The Science of Anti-Aging Medicine. Chicago; American Academy of Anti-Aging Medicine 1996: 15-31 -
12 Cutler R G, Mattson M P.
Measuring oxidative stress and interpreting its clinical relevance for humans. Cutler RG, Rodriguez H Critical Reviews of Oxidative Stress and Aging: Advances in Basic Science, Diagnostics and Intervention. New Jersey; World Scientific 2003: 132-138 -
13 Brown-Borg H M, Harman S M.
Hormones and oxidative stress. Cutler RG, Rodriguez H Critical Reviews of Oxidative Stress and Aging: Advances in Basic Science, Diagnostics and Intervention. New Jersey; World Scientific 2003: 1081-1086 - 14 Huh K, Shin U S, Choi J W, Lee S I. Effect of sex hormones on lipid peroxidation in rat liver. Arch Pharm Res. 1994; 17 109-114
- 15 Ayres S, Abplanalp W, Liu J H, Subbiah M T. Mechanisms involved in the protective effect of estradiol-17 beta on lipid peroxidation and DNA damage. Am J Physiol. 1998; 274 (6 Pt1) E1002-1008
- 16 Bekesi G, Magyar Z, Kakucs R, Sprintz D, Kocsis I, Szekacs B, Feher J. Changes in the myeloperoxidase activity of human neutrophilic granulocytes and the amount of enzyme deriving from them under the effect of estrogen. Orv Hetil. 1999; 140 1625-1630
- 17 Mizutani K, Ikeda K, Nishikata T, Yamori Y. Phytoestrogens attenuate oxidative DNA damage in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Hypertens. 2000; 18 1833-1840
- 18 Mobley J A, Brueggemeier R W. Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis. 2004; 25 3-9
- 19 Barnes J F, Farish E, Rankin M, Hart D M. A comparison of the effects of two continuous HRT regimens on cardiovascular risk factors. Atherosclerosis. 2002; 160 185-193
MD, PhD Seok Hyun Kim
Department of Obstetrics and Gynecology
Seoul National University Hospital
28 Yonkeun-dong, Chongno-gu
Seoul 110-744
Korea
Email: seokhyun@plaza.snu.ac.kr